Literature DB >> 26958510

Concomitant EGFR mutations/ALK rearrangements: beyond a simple dual target.

Domenico Galetta1, Annamaria Catino1, Andrea Misino1.   

Abstract

Entities:  

Year:  2016        PMID： 26958510      PMCID： PMC4758971          DOI： 10.3978/j.issn.2218-6751.2016.01.09

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  5 in total

Review 1.  Concomitant EGFR mutation and ALK rearrangement in lung adenocarcinoma is more frequent than expected: report of a case and review of the literature with demonstration of genes alteration into the same tumor cells.

Authors:  Licia Baldi; Maria Cecilia Mengoli; Alessandra Bisagni; Maria Chiara Banzi; Corrado Boni; Giulio Rossi
Journal:  Lung Cancer       Date:  2014-09-28       Impact factor: 5.705

2.  Lung cancers with concomitant EGFR mutations and ALK rearrangements: diverse responses to EGFR-TKI and crizotinib in relation to diverse receptors phosphorylation.

Authors:  Jin-Ji Yang; Xu-Chao Zhang; Jian Su; Chong-Rui Xu; Qing Zhou; Hong-Xia Tian; Zhi Xie; Hua-Jun Chen; Yi-Sheng Huang; Ben-Yuan Jiang; Zhen Wang; Bin-Chao Wang; Xue-Ning Yang; Wen-Zhao Zhong; Qiang Nie; Ri-Qiang Liao; Tony S Mok; Yi-Long Wu
Journal:  Clin Cancer Res       Date:  2014-01-17       Impact factor: 12.531

3.  Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor.

Authors:  J K Won; B Keam; J Koh; H J Cho; Y K Jeon; T M Kim; S H Lee; D S Lee; D W Kim; D H Chung
Journal:  Ann Oncol       Date:  2014-11-17       Impact factor: 32.976

4.  Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.

Authors:  Anna Karlsson; Markus Ringnér; Martin Lauss; Johan Botling; Patrick Micke; Maria Planck; Johan Staaf
Journal:  Clin Cancer Res       Date:  2014-07-18       Impact factor: 12.531

5.  Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.

Authors:  Henrik H Rossing; Morten Grauslund; Edyta M Urbanska; Linea C Melchior; Charlotte K Rask; Junia C Costa; Birgit G Skov; Jens Benn Sørensen; Eric Santoni-Rugiu
Journal:  BMC Res Notes       Date:  2013-11-26
  5 in total
  1 in total

Review 1.  Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases.

Authors:  Giuseppe Lo Russo; Martina Imbimbo; Giulia Corrao; Claudia Proto; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Laura Botta; Nicoletta Zilembo; Filippo de Braud; Marina Chiara Garassino
Journal:  Oncotarget       Date:  2017-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.